Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

David Yanni

2PUBLICATIONS

2CO-AUTHORS

Disease surveillanceOncology and carcinogenesis not elsewhere classified

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Jul 15, 2026

Azacitidine Is Well-Tolerated and Is Associated with High Response Rate in Elderly Patients with Higher-Risk Myelodysplastic Syndromes: A Single Center Observational Study.

|Mar 14, 2026

Addition of Venetoclax to Azacitidine Did Not Improve Survival in Acute Myeloid Leukemia and Was Not Well Tolerated: Real World Experience.

David Yanni, Nupur Krishnan, Rouslan Kotchetkov

Pageof 1

Frequent Collaborators

2 joint publications

Rouslan Kotchetkov

1 joint publications

Nupur Krishnan

Frequent Collaborators

2 joint publications

Rouslan Kotchetkov

1 joint publications

Nupur Krishnan